Blue Earth Diagnostics Announces Reader Reproducibility Resu

- Oral presentation highlighted at 2022 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting - Blue Earth Diagnostics, a Bracco company and recognized leader in the development

Related Keywords

Germany , Italy , Boston , Massachusetts , United States , Milan , Lombardia , United Kingdom , Munich , Bayern , Phillip Kuo , Scintomics Gmb , Kostenloser Wertpapierhandel , Davide Gauden , Clare Gidley , Mike Beyer , Priscilla Harlan , Study Group , Drug Administration , Sam Brown Inc , Bracco Group , Technical University Of Munich , Nuclear Medicine , Corporate Communications , Society Of Nuclear Medicine , University Of Arizona , Molecular Imaging , Annual Meeting , Earth Diagnostics , Prostate Specific Membrane Antigen Targeted , Business Wire , Medical Imaging , Biomedical Engineering , New Drug Application , Chief Executive Officer , Blue Earth , Blue Earth Diagnostic , Radiohybrid Prostate Specific Membrane Antigen , Technical University , Blue Earth Diagnostics , Scintomics Gmbh , Earth Diagnostic , Bracco Imaging , Interventional Radiology , Cardiac Catheterization , Magnetic Resonance Imaging , Contrast Enhanced Ultrasound , Blue Earth Therapeutics , Director Marketing , Blue , Earth , Iagnostics , Nnounces , Leader , Reproducibility , Results , Rom , Hase , Spotlight , Trial , Investigational , Maging , Agent , Hpsma , Biochemical , Recurrence , Prostate , Dancer ,